[ad_1]

BALA CYNWYD, Pa., July 13, 2022 (GLOBE NEWSWIRE) — Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

ironSource Ltd. (NYSE – IS)

Under the terms of the agreement and plan of merger, ironSource will merge into a wholly-owned subsidiary of Unity via an all-stock deal, where each ordinary share of ironSource will be exchanged for 0.1089 shares of Unity common stock. Once closed, current Unity stockholders will own approximately 73.5% and current ironSource shareholders will own approximately 26.5% of the combined company. The investigation concerns whether the ironSource Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether the Unity is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/ironsource-ltd-nyse/.

Sharps Compliance Corp. (Nasdaq – SMED)

Under the terms of the agreement, Sharps will be acquired by an affiliate of Aurora Capital Partners (“Aurora”). Aurora will commence an all-cash tender offer to acquire all of the issued and outstanding shares of Sharps for $8.75 per share. The investigation concerns whether the Sharps Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether Aurora is paying too little for the Company. For example, the deal consideration is below the 52-week high of $10.47 for the Company’s shares.

Additional information can be found at https://www.brodskysmith.com/cases/sharps-compliance-corp-nasdaq-smed/.

La Jolla Pharmaceutical Company (Nasdaq – LJPC)

Under the terms of the agreement, La Jolla Pharmaceutical will be acquired by Innoviva, Inc. (Nasdaq – INVA). Innoviva will pay $6.23 in cash for each share of La Jolla Pharmaceutical. The investigation concerns whether the La Jolla Pharmaceutical Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether the Innoviva is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/la-jolla-pharmaceutical-company-nasdaq-ljpc/.

USA Truck, Inc. (Nasdaq – USAK)

Under the terms of the agreement, USA Truck will be acquired by DB Schenker in an all-cash transaction that values USA Truck at approximately $435 million. USA Truck shareholders will receive $31.72 per share. The investigation concerns whether the USA Truck Board breached its fiduciary duties to shareholders by failing to conduct a fair process, and whether DB Schenker is paying too little for the Company.

Additional information can be found at https://www.brodskysmith.com/cases/usa-truck-inc-nasdaq-usak/.

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


[ad_2]

Source link